DCGI orders withdrawal of cancer drug Olaparib for certain treatments 0 22.05.2024 21:58 Economictimes.indiatimes.com The Drug Controller General of India has requested the withdrawal of AstraZeneca's Olaparib tablets for certain cancer treatments due to potential adverse effects. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
